SUVN I7016031
Alternative Names: SUVN-I7016031Latest Information Update: 04 Oct 2024
At a glance
- Originator Suven Life Sciences
- Class Antidementias
- Mechanism of Action Muscarinic M1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Dementia